Advertisement

Thrombocytenfaktoren

  • E. F. Lüscher
Conference paper
Part of the Ergebnisse der Physiologie, biologischen Chemie und experimentellen Pharmakologie book series (ERGEBPHYSIOL, volume 50)

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur 1. Übersichtsarbeiten

  1. Aggeler, P. M., J. Howard andS. P. Lucia: Platelet counts and platelet function. Blood1, 472–486 (1946).PubMedGoogle Scholar
  2. Bessis, M.: Traité de cytologie sanguine. Paris 1954.Google Scholar
  3. Biggs, R., andR. G. Macfarlane: Human blood coagulation and its disorders. Oxford 1957.Google Scholar
  4. Burstein, M., etM. Bessis: Etudes sur la physiologie des thrombocytes. Rev. Hémat.3, 69–91 (1948).Google Scholar
  5. Dausset, J.: Immunologie des plaquettes. Immuno-Hématologie Biologique et Clinique. Paris 1956.Google Scholar
  6. Fonio, A., u.J. Schwendener: Die Thrombozyten des menschlichen Blutes. Bern 1942.Google Scholar
  7. Heilmeyer, L., u.H. Begemann: Blut und Blutkrankheiten. In Handbuch der inneren Medizin, Bd. II. Berlin-Göttingen-Heidelberg 1951.Google Scholar
  8. Hittmair, A.: Das Blutplättchen im Schrifttum der letzten 10 Jahre. Fol. haemat. (Lpz.)59, 50–92 (1938).Google Scholar
  9. Jürgens, R., u.E. Deutsch (Herausgeber): Hämorrhagische Diathesen. Internat. Symp. Wien 1955.Google Scholar
  10. Lüscher, E. F.: Die physiologische Bedeutung der Thrombozyten. Schweiz. med. Wschr.1956(a), 345.Google Scholar
  11. Maupin, B.: Les plaquettes sanguines de l’homme. Paris 1954.Google Scholar
  12. Saltzman, G. F.: The origin of blood platelets. Acta med. scand. Suppl.1949, 221.Google Scholar
  13. Seegers, W. H.: Vue actuelle sur le rôle des plaquettes dans la coagulation sanguine. Sang27, 866–883 (1956).PubMedGoogle Scholar
  14. Symposium de la Fondation Valentino Baldacci, Pisa 1955.Google Scholar
  15. Tocantins, L.: The mammalian blood platelet in health and disease. Medicine (Baltimore)17, 155–258 (1938).Google Scholar

2. Originalarbeiten

  1. Abramson, H. A.: Electrophoresis of the blood platelets of the horse with reference to their origin and to thrombus formation J. exp. Med.47, 677 (1928).PubMedGoogle Scholar
  2. Achard, C., etM. Aynaud: Le globulin, Sem. méd. (Paris)29, 169 (1909).Google Scholar
  3. Actes 1. Symposium Fondation V. Baldacci, Pisa 1955.Google Scholar
  4. Achard, C. 2. Symposium Fondation V. Baldacci, Pisa 1959.Google Scholar
  5. Adelson, E.: Mechanism of hemostatic defect caused by intravenous dextran. Clin. Res. Proc.3, 103 (1955).Google Scholar
  6. Aggeler, P. M., J. Howard andS. P. Lucia: Platelet counts and platelet function. Blood 1, 472–486 (1946).PubMedGoogle Scholar
  7. —,S. G. White, M. B. Glendening, E. W. Page, T. B. Leake andG. Bates: Plasma thomboplastin component (PTC)-deficiency: A new disease resembling hemophilia Proc. Soc. exp. Biol. (N. Y.)79, 692 (1952).Google Scholar
  8. Alexander, B.: Blood cells and plasma proteins (J. L. Tullis, Edit.), p. 78. New York 1953.Google Scholar
  9. —,R. Goldstein, L. Rich, A. Le Bolloch, L. K. Diamond andW. Borges: Congenital afibrinogenemia; a study of some basic aspects of coagulation. Blood9, 843 (1954).PubMedGoogle Scholar
  10. Alkjaersig, N., T. Abe andW. H. Seegers: Purification and quantitative determination of platelet factor 3. Amer. J. Physiol.181, 304 (1955).PubMedGoogle Scholar
  11. —, andW. H. Seegers: Formation of prothrombin from autoprothrombin by means of liver mitochondria. Amer. J. Physiol.183, 111 (1955).PubMedGoogle Scholar
  12. Allen, J. G., G. Bogardus, L. O. Jacobson andC. L. Spurr: Some observations on bleeding tendencies in thrombocytopenic purpura. Ann. intern. Med.27, 382 (1947).PubMedGoogle Scholar
  13. Apitz, K.: Über Profibrin: V. Die Agglutination von Blutplättchen durch Profibrin. Z. ges. exp. Med.105, 89 (1939).Google Scholar
  14. Arneth, J.: Die Blutplättchen und ihr qualitatives Blutbild. Ärzt. Wschr.1948, 225.Google Scholar
  15. Astrup, T.: Fibrinolysis in the organism. Blood11, 781 (1956).PubMedGoogle Scholar
  16. Augustinsson, K. B., N. Datta, M. Grahn andJ. Zajicek: Acetylcholinesterase in thrombocytes. Nature (Lond.)169, 800 (1952).Google Scholar
  17. Axelrod, S. L.: Some effects of ultrasonic energy upon blood coagulation. J. Lab. clin. Med.48, 690 (1956).PubMedGoogle Scholar
  18. Bachmann, F., F. Duckert, M. Geiger, P. Baer andF. Koller: Differentiation of the factor VII complex. Studies on the Stuart-Prower factor. Thromb. Diath. haem.1, 169 (1957).Google Scholar
  19. Bailey, K., W. T. Astbury andK. M. Rudall: Fibrinogen and fibrin as members of the keratin-myosin group. Nature (Lond.)151, 716 (1943).Google Scholar
  20. Ballerini, G.: 5-OH-triptamina e retrazione del coagulo. Progr. med. (Napoli)11, 455 (1955).Google Scholar
  21. Baserga, A.: Les facteurs plaquettaires. Sang.25, 742 (1954).PubMedGoogle Scholar
  22. Baserga, A., etG. Ballerini: La résistance osmotique des plaquettes. Schweiz. med. Wschr.1957, 1218.Google Scholar
  23. Baumgartner, W.: Klinische Demonstrationen. Helv. med. Acta,23, 311 (1956).PubMedGoogle Scholar
  24. Bell, W. N., andH. G. Alton: A brain extract as a substitute for platelet suspensions in the thromboplastin generation test. Nature (Lond.)174, 880 (1954).Google Scholar
  25. Bergsagel, D. E.: The role of calcium in the activation of Christmas factor. Brit. J. Haemat.1, 199 (1955).PubMedGoogle Scholar
  26. —: Viscous metamorphosis of blood platelets: Morphological platelet-changes induced by an intermediate product of blood thromboplastin. Brit. J. Haemat.2, 130 (1956).PubMedGoogle Scholar
  27. —, andR. Biggs: The Christmas factor. Rev. Hémat.10, 354 (1955).PubMedGoogle Scholar
  28. —, andC. Hougie: Intermediate stages in the formation of blood thromboplastin. Brit. J. Haemat.2, 113 (1956).PubMedGoogle Scholar
  29. Bernhard, W., etR. Leplus: La methode des coupes ultrafines et son application à l’étude de l’ultrastructure des cellules sanguines. Schweiz. Med. Wschr.1955, 897.Google Scholar
  30. Bertrand, I., etD. Quivy: Evaluation au cours des dosages d’héparine de l’inter-action héparine-thrombokinase. Arch. int. Pharmacodyn.79, 173 (1949).PubMedGoogle Scholar
  31. Bessis, M.: Une méthode permettant l’isolement des differents éléments figurés du sang. Sang14, 262 (1940).Google Scholar
  32. Bessis, M.: Traité de cytologie sanguine. Paris 1954.Google Scholar
  33. Bessis, M.: The cytology of the blood-forming organs. New York 1956.Google Scholar
  34. —, etJ. Tabuis: Aspect dynamique des plaquettes sanguines. Rev. Hémat.10, 753 (1955).Google Scholar
  35. Bestetti, A., eP. F. Crosti: Ricerche cliniche sulle piastrine I., III. Atti Soc. lombarda Sci. med. biol.10, 278, 284 (1955).Google Scholar
  36. —,P. Lucchelli eP. F. Crosti: Ricerche cliniche sulle piastrine II. Atti. Soc. lombarda Sci. med. biol.10, 281 (1955).Google Scholar
  37. Bidwell, E., andR. Biggs: Development of platelet-like activity on storage of crude egg phospholipid. J. Physiol. (Lond.)138, 37 P (1957).Google Scholar
  38. Bierstedt, P.: Die Beteiligung der Thrombocyten an der Fibrinolyse, Abstr. 6. Congr. Soc. Europ. Hematol. Kopenhagen 1957.Google Scholar
  39. Bigelow, F. S., andJ. F. Desforges: The mobility of human platelets in a microelectrophoresis cell. Amer. J. Med.14, 495 (1953).Google Scholar
  40. Biggs, R.: Plasma Thromboplastin. Nature (Lond.)170, 280 (1952).Google Scholar
  41. —, andE. Bidwell: An attempt to identify a single phospholipid active in blood coagulation. Brit. J. Haemat.3, 387 (1957).PubMedGoogle Scholar
  42. —, andA. S. Douglas: The thromboplastin generation test. J. clin. Path.6, 23 (1953).PubMedGoogle Scholar
  43. ——, andR. G. Macfarlane: The formation of thromboplastin in human blood. J. Physiol. (Lond.)119, 89 (1953) (a).Google Scholar
  44. ———: The action of thromboplastic substances. J. Physiol. (Lond.)122, 538 (1953) (b).Google Scholar
  45. Biggs, R., andA. S. Douglas, andR. G. Macfarlane, J. V. Dacie, W. R. Pitney, C. Merskey andJ. R. O’Brien: Christmas disease, a condition previously mistaken for haemophilia. Brit. med. J.1952, 1378.Google Scholar
  46. Biggs, R., andR. G. Macfarlane: Human blood coagulation and its disorders, 2. edit. Oxford 1957.Google Scholar
  47. Bizzozero, J.: Über einen neuen Formbestandteil des Blutes und dessen Rolle bei der Thrombose und der Blutgerinnung. Virchows Arch. path. Anat.90, 261 (1882).Google Scholar
  48. Bloom, G.: The morphology of human blood platelets and the coagulation of human bloodin vitro. Z. Zellforsch.42, 365 (1955).PubMedGoogle Scholar
  49. Bordet, J., etL. Delange: La coagulation du sang et la génèse de la thrombine. Ann. Inst. Pasteur26, 657, 739 (1912).Google Scholar
  50. Born, G. V. R.: The breakdown of adenosine triphosphate in blood platelets during clotting. J. Physiol. (Lond.)133, 61 P (1956).Google Scholar
  51. —: Evidence for the formation of a labile phospholipoprotein during the clotting of platelet-rich plasma. Nature (Lond.)180, 546 (1957).Google Scholar
  52. Born, G. V. R., andO. Hornykiewicz: The proportionality between the uptake of adrenaline by blood platelets and their content of adenosin triphosphate. J. Physiol. (Lond.)136, 30 P (1957).Google Scholar
  53. Born, G. V. R. G. I. C. Ingram andR. S. Stacey: The proportionality between the amount of 5-hydroxytryptamine and adenosine triphosphate in blood platelets. J. Physiol. (Lond.)135, 63 P (1957).Google Scholar
  54. Bounameaux, Y.: Recherches sur le mécanisme de l’adhésivité des plaquettesin vitro. Etudes sur l’atmosphère plasmatique. Arch. int. Physiol.63, 531 (1955) (a).PubMedGoogle Scholar
  55. —: Thrombine et agglutination plaquettaire. Arch. int. Physiol.63, 243 (1955) (b).PubMedGoogle Scholar
  56. —: Recherches sur le mécanisme de la rétraction du caillot et de la métamorphose visqueuse des plaquettes. Experientia (Basel)12, 355 (1956).Google Scholar
  57. —: Recherches sur le mécanime de la formation de la thromboplastine sanguine. Acta haemat. (Basel)17, 65 (1957) (a).Google Scholar
  58. —: Dosage des facteurs de coagulation contenus dans l’atmosphère plasmatique des plaquettes humaines. Rev. franç. Ét. clin. biol.2, 52 (1957) (b).Google Scholar
  59. —: Sur le mécanisme de la rétraction du caillot et de la métamorphose visqueuse des plaquettes. Rev. Hémat.12, 16 (1957)(c).PubMedGoogle Scholar
  60. Bracco, M., andP. C. Curti: The vaso-constrictor factor of platelets. Experientia (Basel)10, 71 (1954).Google Scholar
  61. Brambel, C. E., A. H. Corwin andV. A. Capone: Mechanism of action of heparin as an etiological basis for homeostasis (Hemorrhage and thrombosis). Amer. J. med. Sci.230, 276 (1955).PubMedGoogle Scholar
  62. Braunsteiner, H.: Über Morphologie, Physiologie und Pathologie der Thrombocyten. Klin. Wschr.1951, 835.Google Scholar
  63. —,K. Fellinger andF. Pakesch: Structural changes in the platelets as observed by electron microscopy. Blood9, 595 (1954).PubMedGoogle Scholar
  64. —,F. Pakesch u.H. Vetter: Isolierung und Anreicherung funktionsrichtiger Leucozyten und Thrombozyten mittels Polyvinyl-Pyrrolidon. Acta haemat. (Basel)8, 304 (1952).Google Scholar
  65. Brinkhous, K. M.: A study of the clotting time in hemophilia: The delayed formation of thrombin. Amer. J. Med. Sci.198, 509 (1939).Google Scholar
  66. —: Clotting defect in hemophilia. Deficiency in a plasma factor required for platelet utilization. Proc. Soc. exp. Biol. (N. Y.)66, 117 (1947).Google Scholar
  67. —,H. P. Smith, E. D. Warner andW. H. Seegers: Inhibition of blood clotting: an unidentified substance which acts in conjunction with heparin to prevent the conversion of prothrombin into thrombin. Amer. J. Physiol.125, 683 (1939).Google Scholar
  68. Brönnimann, R.: Kongenitale Afibrinogenämie: Mitteilung eines Falles mit multiplen Knochencysten und Bildung eines spezifischen Antikörpers (Antifibrinogen) nach Bluttransfusionen. Acta haemat. (Basel)11, 41 (1954).Google Scholar
  69. Budtz-Olsen, O. E.: Clot retraction. Oxford 1951.Google Scholar
  70. Burstein, M., etM. Bessis: Etudes sur la physiologie des thrombocytes. Rev. Hémat.3, 69–91 (1948).Google Scholar
  71. —, etJ. Loeb: L’inhibition de la thrombinoformation par l’héparine. Rev. franç. Ét. clin. biol.1, 752 (1956).Google Scholar
  72. Cajano, A., eP. Polosa: Contributo allo studio della morfologia dei megacariociti e delle piastrine con la reazione di Feulgen. Haematologia34, 1113 (1950).Google Scholar
  73. Campbell, E. W., andW. J. Small: Metabolic functions of human platelets. J. clin. Invest.35, 695 (1956).Google Scholar
  74. ——, andW. Dameshek: Metabolic activity of human blood platelets I. J. Lab. clin. Med.47, 835 (1956).PubMedGoogle Scholar
  75. Campbell, E. W., W. J. Small andE. Lo Pilato: Comparative study of carbohydrate metabolism of human platelets. Proc. 6. Congr. Int. Soc. Hematol., Boston 1956, p. 523. New York 1958.Google Scholar
  76. ——— andW. Dameshek: Glycolytic intermediates of human platelets. Their separation and identification. Proc. Soc. exp. Biol. (N. Y.)94, 505 (1957).Google Scholar
  77. Chambers, R., andB. W. Zweifach: Intercellular cement and capillary permeability. Physiol. Rev.27, 436 (1947).PubMedGoogle Scholar
  78. Chargaff, E., F. W. Bancroft andM. Stanley-Brown: Studies on the chemistry of blood coagulation: III. The chemical constituents of blood platelets and their role in blood clotting with remarks on the activation of clotting by lipids. J. biol. Chem.116, 237 (1936).Google Scholar
  79. —,A. Bendich andS. S. Cohen: The thromboplastic protein: structure, properties, disintegration. J. biol. Chem.156, 161 (1944).Google Scholar
  80. —,M. Ziff andS. S. Cohen: Studies on the chemistry of blood coagulation; X. The reaction between heparin and the thromboplastic factor. J. biol. Chem.136, 257 (1940).Google Scholar
  81. Chen, T. L., andL. Tsai: The mechanism of haemostasis in peripheral vessels. J. Physiol. (Lond.)107, 280 (1948).Google Scholar
  82. Chevalier, P., A. Fiehrer etM. Samama: En marche de l’hémophilie: La déficience en facteur Hageman. Sang27, 950 (1956).Google Scholar
  83. Chevillard, L.: Sur les phospho-monoestérases de la moelle du fémur, des ganglions lymphatiques, des leucocytes d’exsudats chez le cobaye, et des plaquettes sanguines chez le lapin. C. R. Soc. Biol. (Paris)139, 249 (1945).Google Scholar
  84. —: Sur les pyrophosphatases de la moelle du fémur, des ganglions lymphatiques, des leucocytes d’exsudats chez le cobaye, et des plaquettes sanguines chez le lapin. C. R. Soc. Biol. (Paris)140, 955 (1946).Google Scholar
  85. Code, C. F.: Histamine in blood. Physiol. Rev.32, 47 (1952).PubMedGoogle Scholar
  86. Cohn, E. J.: Conference on: “The separation and the preservation of the formed elements and of the plasma proteins of human blood”, p. 24, Boston 1950.Google Scholar
  87. Cole, J. W., H. Livingston, C. W. Loughry andW. D. Holden: Vasoconstrictor activity of blood platelets. Surgery34, 482 (1953).PubMedGoogle Scholar
  88. Conley, C. L., R. C. Hartmann andJ. S. Lalley: The relationship of heparin activity to platelet concentration. Proc. Soc. exp. Biol. (N. Y.)69, 284 (1948).Google Scholar
  89. —— andW. I. Morse: The clotting behaviour of human “platelet-free” plasma. Evidence for the existence of a plasma thromboplastin. J. clin. Invest.28, 340 (1949).Google Scholar
  90. Connor, W. E., andJ. R. Carter: Influence of soybean phosphatide on blood coagulation and its use in the thromboplastin generation test. Proc. Soc. exp. Biol. (N. Y.)97, 38 (1958).Google Scholar
  91. Copley, A. L.: Embolization of platelet agglutination thrombi in the hamster pouch produced by heparin. Fed. Proc.7, 22 (1948).PubMedGoogle Scholar
  92. —: Effect capillarogique de la fibrinolysine. Arch. int. Pharmacodyn.99, 426 (1954).PubMedGoogle Scholar
  93. —: Neue Anschauungen über Haemorrhagie, Haemostase und Thrombose. Ärztl. Forsch.11, 114 (1957).Google Scholar
  94. —,T. Baléa etVo-Vinh-Hoa: Microméthode pour l’isolement des plaquettes sanguines chez l’homme et chez les petits mammifères. Rev. Hémat.11, 324 (1956).PubMedGoogle Scholar
  95. —, andD. F. Glaser: Studies on platelets. V. The effects of platelets on the surface tension of saline solutions and heparinized plasma. Blood (special issue)1, 161 (1947).Google Scholar
  96. —, andR. B. Houlihan: On the mechanism of platelet agglutination. Fed. Proc.4, 173 (1945).Google Scholar
  97. ——: Morphologic hematology. Blood (special issue)1, 182 (1947).Google Scholar
  98. —, andT. P. Robb: Studies on platelets. II. The effect of heparin on the platelet countin vitro. Amer. J. clin. Path.12, 416 (1942).Google Scholar
  99. Creveld, S. van: Functional pathology of the platelets. Acta haemat. (Basel)12, 229 (1954).Google Scholar
  100. Creveld, S. van, andM. M. P. Paulssen: Significance of clotting factors in blood platelets, in normal and pathological conditions. Lancet1951 II, 242.Google Scholar
  101. Creveld, S. van, andM. M. P. Paulssen: Isolation and properties of the third clotting factor in blood platelets. Lancet1952 I, 23.Google Scholar
  102. Csefkó, I., M. Gerendás andM. D. F. Unwardy: Kinase-heparin antagonismin vitro. Arch. biol. Hung.18, 186 (1948).Google Scholar
  103. Danielli, J. F.: Capillary permeability and oedema in the perfused frog. J. Physiol. (Lond.)98, 109 (1940).Google Scholar
  104. —, andJ. T. Davies: Retractions at interfaces in relation to biological problems. Enzymol.11, 35 (1951).Google Scholar
  105. Datta, N., andJ. Zajicek: Presence of pyrophosphatase in platelets. Acta haemat. (Basel)12, 81 (1954).Google Scholar
  106. Dausset, J.: Editorial. Vox Sang. (Basel)1, 63 (1956) (a).Google Scholar
  107. Dausset, J.: Immuno-hématologie. Biologique et clinique. Paris 1956(b).Google Scholar
  108. —, andG. Malinvaud: Normal and pathological platelet agglutinins investigated by means of the shaking method. Confirmation of the presence of A and B antigens in platelets. Vox Sang. (Basel)4, 204 (1954).Google Scholar
  109. Delezenne, E.: Recherches sur la coagulation du sang chez les oiseaux. Arch. Physiol.9, 333 (1897).Google Scholar
  110. Desforges, J. F., andF. S. Bigelow: An action of thrombin on platelets in accelerating clotting. Blood9, 153 (1954).PubMedGoogle Scholar
  111. Deutsch, E.: Der Wirkungsmodus von “Hämostypticum 733 Schoch”. Arzneimittel-Forsch.2, 470 (1952).Google Scholar
  112. —: Differentiation of certain platelet factors in relation to blood coagulation. Rev. Hémat.9, 483 (1954).PubMedGoogle Scholar
  113. Deutsch, E.: Blutgerinnungsfaktoren. Wien 1955(a).Google Scholar
  114. —: Über die Thrombokinasebildung und das Verhalten von Thrombozytenfaktor 1 bei Hypoproaccelerinämie (Parahämophilie). Wien. Z. inn. Med.36, 355 (1955)(b).PubMedGoogle Scholar
  115. Deutsch, E.: Thrombozytenfaktoren. Hämorrhagische Diathesen. Wien, S. 169. 1955(c).Google Scholar
  116. Deutsch, E.: Pathophysiologie der plasmatisch bedingten Coagulopathien. Hämorrhagische Diathesen, S. 83. Wien 1955(d).Google Scholar
  117. —,Sh. A. Johnson andW. H. Seegers: Differentiation of certain platelet factors related to blood coagulation. Circulat. Res.3, 110 (1955).PubMedGoogle Scholar
  118. —, u.W. Schaden: Zur Reinigung und Charakterisierung des VII. Blutgerinnungsfaktors. Biochem. Z.324, 266 (1953).PubMedGoogle Scholar
  119. Deutsch, E., E. Wawersich andG. Franke: The relation of different platelet factors to brain thromboplastin. Proc. 6. Congr. Int. Soc. Hematol., Boston 1956, p. 477. New York 1958.Google Scholar
  120. ———: Über das Vorkommen eines Antiheparinfaktors in Thrombozyten und Geweben. I. Mitt.: Antiheparinaktivität der Thrombozyten. Thromb. Diath. haem.1, 397 (1957) (a); II. Mitt.: Antiheparinaktivität von Hirnextrakten. Thromb. Diath. haem.1, 406 (1957) (b).Google Scholar
  121. Dick, F. W., D. P. Jackson andC. L. Conley: Surface as a quantitative factor in prothrombin utilization. J. clin. Invest.33, 1423 (1954).PubMedGoogle Scholar
  122. Discombe, G.: Phase contrast microscopy. Acta haemat. (Basel)3, 151 (1950).Google Scholar
  123. Djerassi, I., E. Klein andV. Lauris: Human platelet material and thrombin activity. Proc. 6. Congr. Int. Soc. Hematol., Boston 1956, p. 55. New York 1958.Google Scholar
  124. Donné, A.: De l’origine des globules du sang, de leur modes de formation, de leur fin. C. R. Acad. Sci. (Paris)14, 366 (1842).Google Scholar
  125. Douglas, A. S.: Antihaemophilic globulin consumption during blood coagulation. Blood11, 423 (1956)(a).PubMedGoogle Scholar
  126. —: Factor V consumption during blood coagulation. Brit. J. Haemat.2, 153 (1956)(b).PubMedGoogle Scholar
  127. —: The action of heparin in the prevention of prothrombin-conversion. J. clin. Invest.35, 533 (1956(c).PubMedGoogle Scholar
  128. Dreskin, O. H.: Two stage prothrombin analysis using hemolyzed whole blood thromboplastin. Clin. Res. Proc.3, 32 (1955).Google Scholar
  129. Dreyfuss, A.: Etudes sur la morphologie des plaquettes sanguines. 1° La formule thrombocytaire à l’état normal. Sang11, 557 (1937).Google Scholar
  130. Duckert, F., P. Flückiger, H. Isenschmid, M. Matter, J. Vogel-Meng andF. Koller: A modification of the thromboplastin generation test. Acta haemat. (Basel)12, 197 (1954).Google Scholar
  131. Duguid, J. B.: The arterial lining. Lancet1952 II, 207.Google Scholar
  132. Ebbeke, U.: Über die Fibringerinnung als Polymerisations-Kristallisationsvorgang. Biochem. Z.304, 177 (1940).Google Scholar
  133. Eberth, J. C., u.C. Schimmelbusch: Die Blutplättchen und die Blutgerinnung. Virchows Arch. path. Anat.101, 201 (1885).Google Scholar
  134. ——: Experimentelle Untersuchungen über Thrombose. Virchows Arch. path. Anat.103, 39 (1886).Google Scholar
  135. Eiseman, G., andM. Stefanini: Thromboplastic activity of leukemic white cells. Proc. Soc. exp. Biol. (N. Y.)86, 763 (1954).Google Scholar
  136. Ellicott, C. E., andC. L. Conley: Retraction of clots formed from purified prothrombin. Bull. Johns Hopk. Hosp.88, 321 (1952).Google Scholar
  137. Emerson, C. P.: A practical procedure for the individual separation and removal of erythrocytes, leukocytes and platelets from human blood. Proceedings of the Conference on the Preservation of the formed elements and of the Proteins of the Blood, Boston 1949.Google Scholar
  138. Endres, G., u.L. Herget: Mineralzusammensetzung der Blutplättchen und weißen Blutkörperchen. Z. Biol.88, 451 (1929).Google Scholar
  139. —, u.F. Kubowitz: Stoffwechsel der Blutplättchen. Biochem. Z.191, 395 (1927).Google Scholar
  140. Epstein, E., u.A. Goedel: Haemorrhagische Thrombozythämie bei vasculärer Schrumpfmilz. Virchows Arch. path. Anat.292, 233 (1934).Google Scholar
  141. Epstein, E., u.J. Kretz: Über einen Fall von hochgradiger Thrombozytenvermehrung. Klin. Wschr.1930, 1177.Google Scholar
  142. —, andA. J. Quick: Effect of injecting platelet extract intravenously. Proc. Soc. exp. Biol. (N. Y.)83, 453 (1953).Google Scholar
  143. Erickson, B. N., H. H. Williams, I. Avrin andP. Lee: The lipid distribution in human platelets in health and diseases. J. clin. Invest.18, 81 (1939).PubMedGoogle Scholar
  144. Erkelens, A. D.: De plaats der thrombocyten in het stollingsproces. Rotterdam 1956.Google Scholar
  145. Fanger, H., L. J. Cella jr. andH. Litchman: Thrombocythemia. Report of three cases and review of the literature. New Engl. J. Med.250, 456 (1954).PubMedGoogle Scholar
  146. Feissly, R.: Recherches sur la nature et l’origine de la thrombokinase plasmatique. Helv. med. Acta12, 215 (1945).Google Scholar
  147. Feissly, R.: Comportement du plasma et des éléments figurés du sang en présence de parois mouillables et non mouillables. Compt. rend. 3. Congr. Soc. Europ. Hématol., S. 798. Rome 1951.Google Scholar
  148. Feissly, R.: Actes 2. Symp. Fondation V. Baldacci, Pisa 1959.Google Scholar
  149. —,A. Gautier etI. Marcovici: Nouveau procédé d’examen des thrombocytes au microscope électronique. Rev. Hémat.12, 397 (1957).PubMedGoogle Scholar
  150. Feldman, D., andD. Kirman: Effect of ultrasonics on thromboplastinase-labile components and toxicity of injected thromboplastin. Proc. Soc. exp. Biol. (N. Y.)94, 695 (1957).Google Scholar
  151. Fenichel, R. L.: Bovine platelets, serotonin and the retraction of human plasma clots. Clin. Chem.2, 281 (1956).Google Scholar
  152. —, andW. H. Seegers: Bovine platelets, serotonin and the retraction of bovine plasma clots. Amer. J. Physiol.181, 19 (1955).PubMedGoogle Scholar
  153. ——: Studies on human clot retraction. J. appl. Physiol.10, 71 (1957).PubMedGoogle Scholar
  154. Ferguson, J. H.: The present status of the platelets in coagulation. Trans. 2. Conf. of Josiah Macy Fondation on blood clotting and allied problems, p. 210, New York 1949.Google Scholar
  155. —, andB. N. Erickson: The coagulant action of crystalline trypsin, cephalin and lung extracts. Amer. J. Physiol.126, 661 (1939).Google Scholar
  156. Fishman, W. H., B. Springer andR. Brunetti: Study of human blood β-glucuronidase. J. biol. Chem.173, 449 (1948).PubMedGoogle Scholar
  157. Fonio, A.: Neuere Untersuchungen über Blutgerinnung. Schweiz. Med. Wschr.1923, 36.Google Scholar
  158. —: La fonction rétractile des thrombocytes à l’état normal et dans les états pathologiques de l’homme. Bull. schweiz. Akad. med. Wiss.4, 470 (1948).PubMedGoogle Scholar
  159. Fonio, A.: Eine neue Methode zur Kontrolle der Wirkung von Antikoagulantienin vivo undin vitro. Schweiz. Med. Wschr.1950, 1095.Google Scholar
  160. —: Über das funktionelle Verhalten der isolierten Strukturelemente der Thrombocyten, des Hyalomers und des Granulomers. Acta haemat. (Basel)6, 207 (1951).Google Scholar
  161. —: Über die Wirkung des Hyalomers der Thrombocyten auf den Retraktionsvorgang. Acta haemat. (Basel)8, 363 (1952).Google Scholar
  162. Fonio, A.: Über die Morphologie und den Gestaltswandel der hämophilen Thrombozyten. Schweiz. med. Wschr.1956, 1439.Google Scholar
  163. Fonio, A., u.J. Schwendener: Die Thrombocyten des menschlichen Blutes. Bern 1942.Google Scholar
  164. Freeman, G.: Method for obtaining large yields of human platelets as a by-product of blood collection. Science114, 527 (1951).PubMedGoogle Scholar
  165. Frick, P. G., andP. S. Hagen: Severe coagulation defect without hemorrhagic symptoms caused by a deficiency of the 5th plasma thromboplastin precursor. J. Lab. clin. Med.47, 592 (1956).PubMedGoogle Scholar
  166. Fujita, A.: Über den Stoffwechsel der weißen Blutzellen. Klin. Wschr.1928, 897.Google Scholar
  167. Garrett, J. V.: The platelet-like activity of certain brain extracts. J. Lab. clin. Med.47, 752 (1956).PubMedGoogle Scholar
  168. —, andE. Klein: Differentiation of antiheparin and thromboplastin generating factors in human platelets. Proc. Soc. exp. Biol. (N. Y.)96, 823 (1957).Google Scholar
  169. Glanzmann, E.: Hereditäre hämorrhagische Thrombasthenie. Jb Kinderheilk.88, 113 (1918).Google Scholar
  170. Goldstein, R., andB. Alexander: Coagulation factors concerned with thromboplastin generation. Fed. Proc.14, 219 (1955).Google Scholar
  171. Goldstein, R., B. Alexander, andE. B. Zonderman: The role of proconvertin in citrate or thromboplastin conversion of prothrombin. Proc. 6. Congr. Int. Soc. Hematol., Boston 1956, p. 598. New York 1958.Google Scholar
  172. Gollub, S.: Action of thromboplastinase on human blood thromboplastin J. appl. Physiol.7, 409 (1955).PubMedGoogle Scholar
  173. Goucher, Ch. R., andW. Kocholaty: Reflectance spectra and some respiratory reactions of bovine, equine and human erythrocytes. Amer. J. Physiol.188, 415 (1957).PubMedGoogle Scholar
  174. Graham, H. T., O. H. Lowry, F. Wheelwright, M. A. Lenz andH. H. Parish: Distribution of histamine among leucocytes and platelets. Blood10, 467 (1955).PubMedGoogle Scholar
  175. Greene, R. W.: Effects of pH on platelets and identification of ribonucleoprotein from platelets. Proc. Soc. exp. Biol. (N. Y.)87, 412 (1954).Google Scholar
  176. —: Effects of thrombin and platelet concentrations and of clot retraction on fibrin strand width. J. clin. Invest.34, 417 (1955).PubMedGoogle Scholar
  177. Gross, R., u.G. Schwick: Über die Gerinnungsaktivität und intravenöse Anwendung lyophil getrockneter menschlicher Thrombozyten. Klin. Wschr.1957, 814.Google Scholar
  178. Gurevitch, J. andD. Nelken: ABo groups in blood platelets. Nature (Lond.)173, 356 (1954).Google Scholar
  179. Guttman, W.: Die Kernsubstanzen der Blutplättchen. Z. ges. inn. Med.2, 362 (1947).Google Scholar
  180. Halick, P., andW. H. Seegers: Antigenic properties of purified bovine prothrombin. Amer. J. Physiol.187, 103 (1956).PubMedGoogle Scholar
  181. Hardisty, R. M., G. I. C. Ingram andR. S. Stacey: Reserpine and human platelet-5-hydroxytryptamine. Experientia (Basel)12, 424 (1956).Google Scholar
  182. —, andR. S. Stacey: 5-hydroxytryptamine in normal human platelets. J. Physiol. (Lond.)130, 711 (1955).Google Scholar
  183. Hartert, H.: Thrombelastographische Untersuchungen zur Thrombusbildung. Klin. Wschr.1949, 789.Google Scholar
  184. Hartert, H.: Thrombelastographische Untersuchungen zur Retraktion. Klin. Wschr.1950, 78.Google Scholar
  185. Hartert, H.: Ein Retraktions-Cofaktor im Serum. Klin. Wschr.1954, 139.Google Scholar
  186. —,H. G. Lasch u.I. Pfisterer: Charakterisierung und Funktion eines Retraktions-Cofaktors. Thromb. Diath. haem.1, 445 (1957).Google Scholar
  187. Hartmann, R. C., C. L. Conley andJ. S. Lalley: Studies on the initiation of blood coagulation. I. The relationship of platelets to the clot promoting effect of glass surfaces. Bull. Johns Hopk. Hosp.85, 231 (1949).Google Scholar
  188. Hasché, E.: Über thrombinfreie Fibrinentstehung im menschlichen Plasma. Naturwiss.43, 202 (1956).Google Scholar
  189. Haurowitz, F., u.J. Sladek: Über die chemische Zusammensetzung der Blutplättchen. Hoppe-Seylers Z. physiol. Chem.173, 233 (1928).Google Scholar
  190. Haverback, B. J., T. F. Dutcher, P. A. Shore, E. G. Tomich, L. L. Terry andB. B. Brodie: Serotonin changes in platelets and brain induced by small daily doses of reserpine. New Engl. J. Med.256, 343 (1957).PubMedGoogle Scholar
  191. Hawn, C. van Zandt andK. R. Porter: The fine structure of clots formed from purified bovine fibrinogen and thrombin: A study with the electron microscope. J. exp. Med.86, 284 (1947).Google Scholar
  192. Hayem, G.: Recherches sur l’évolution des hématies dans le sang de l’homme et des vertébrés. Arch. Physiol. norm.5, 692 (1878).Google Scholar
  193. —: Sur le mécanisme de l’arrêt des hémorrhagies. C. R. Acad. Sci. (Paris)95, 18 (1882)Google Scholar
  194. Hayem, G.: Du sang et ses altérations anatomiques. Paris 1889.Google Scholar
  195. Hecht, E.: Untersuchungen über die chemische Natur der Gerinnungsaktivatoren. Sang21, 486 (1950).PubMedGoogle Scholar
  196. —: Wechselwirkungen zwischen fördernden und hemmenden Substanzen der Blutgerinnung. Experientia (Basel)10, 428 (1954).Google Scholar
  197. —: Over de thrombocytenfactor 3 (“T 3”). Ned. T. Geneesk.101, 429 (1957) (a).Google Scholar
  198. —: Studien über den lipoiden Aktivator der Blutgerinnung. Thromb. Diath. haem.1, 380 (1957) (b).Google Scholar
  199. —,R. H. Landaburu andW. H. Seegers: Sphingosine as inhibitor of prothombin activation with thromboplastin or with threone. Amer. J. Physiol.189, 203 (1957).PubMedGoogle Scholar
  200. —, u.D. Shapiro: Versuche zur chemischen Identifikation und Synthese von Gerinnungsfaktoren. Thromb. Diath. haem.1, 359 (1957) (a).Google Scholar
  201. —: Sphingosine as an inhibitor of blood clotting. Science125, 1041 (1957) (b).PubMedGoogle Scholar
  202. Heilemyer, L., u.H. Begemann: Blut und Blutkrankheiten. In Handbuch der inneren Medizin, Bd. II. Berlin-Göttingen-Heidelberg 1951.Google Scholar
  203. Hirose, R. S.: The second phase of thrombin action: Fibrin resolution. Amer. J. Physiol.107, 693 (1934).Google Scholar
  204. Hittmair, A.: Das Blutplättchen im Schrifttum der letzten 10 Jahre. Folia haemat. (Lpz.)59, 50–92 (1938).Google Scholar
  205. Hitzenberger, G., u.E. Keibl: Cytochemische Untersuchungen zur Frage der Thrombozytenabstammung. Wien. klin. Wschr.1954, 669.Google Scholar
  206. Hjort, P., S. I. Rapaport andP. A. Owren: Platelet accelerator identical to proaccelerin and adsorbed from plasma. Scand. J. clin. Lab. Invest.7, 97 (1955) (a).PubMedGoogle Scholar
  207. ———: Evidence that platelet accelerator (platelet factor 1) is adsorbed plasma accelerin. Blood10, 1139 (1955) (b).PubMedGoogle Scholar
  208. Holst, E. J.: Hemorrhagic thrombocythemia. Acta med. scand.130, 507 (1948).PubMedGoogle Scholar
  209. Horwitz S.: Neuere Untersuchungen an Blutplättchen: II. Das Thrombozytenvolumen. Z. ges. exp. Med.73, 434 (1930).Google Scholar
  210. Hougie, C., E. M. Barrow andJ. B. Graham: Stuart clotting defect: I. Segregation of an hereditary hemorrhagic state from the heterogenous group, heretofore called: “stable factor” (SPCA, Proconvertin, F. VII)-deficiency. J. clin. Invest.36, 485 (1957).PubMedGoogle Scholar
  211. Hougie, C., E. M. Barrow andJ. B. Graham: Stuart factor: A hitherto unrecognized blood coagulation factor. Proc. 6. Congr. Inst. Soc. Blood Transfusion, Boston 1956, p. 336. Basel u. New York 1958.Google Scholar
  212. Houlihan, R. B., andA. L. Copley: The adhesion of rabbit platelets to bacteria. J. Bact.52, 439 (1946).Google Scholar
  213. Howell, W. H.: Structure of the fibrin gel and theories of gel formation. Amer. J. Physiol.40, 526 (1916).Google Scholar
  214. —, andE. Holt: Two new factors in blood coagulation: Heparin and pro-antithrombin. Amer. J. Physiol.47, 328 (1918).Google Scholar
  215. Hugues, J.: Actes 2. Symp. Fondation V. Baldacci, Pisa 1959.Google Scholar
  216. Hutter, R. V. P.: Electron microscopic observations on platelets from human blood. Amer. J. Clin. Path.28, 447 (1957).Google Scholar
  217. Iglauer, K., u.S. Weber: Die Katalasewirkung der Thrombozyten. Biochem. Z.234, 489 (1931).Google Scholar
  218. Isenschmid, H.: Über die Wirkung des Thrombins in Thrombokinasebildungstest. Acta haemat. (Basel)13, 177 (1955).Google Scholar
  219. Iyengar, N. K.: Trypsin-kinase in blood. Proc. Ind. Acad. Sci. B15, 106 (1942).Google Scholar
  220. Jaques, L. B., E. Fidlar, E. T. Feldsted andA. S. Macdonald: Silicones and blood coagulation. Canad. med. Ass. J.55, 26 (1946).Google Scholar
  221. Johnson, J. F., andW. H. Seegers: Techniques in blood coagulation used at Wayne University, Detroit 1953.Google Scholar
  222. Johnson, S. A.: Activation of purified prothrombin with hemophilic plasma. Amer. J. clin. Path.23, 875 (1953).Google Scholar
  223. —, andC. L. Schneider: The existence of antifibrinolysin activity in platelets. Science117, 229 (1953).PubMedGoogle Scholar
  224. —,W. M. Smathers andC. L. Schneider: Platelets and their plasma cofactor activity in the activation of purified prothrombin. Amer. J. Physiol.170 631 (1952).PubMedGoogle Scholar
  225. Jürgens, R.: Die Blutplättchen und ihre Bedeutung für Blutungsneigung und Thrombusbildung. Dtsch. med. Wschr1952, 1265.Google Scholar
  226. —: Pharmakologische Beeinflussung der Blutgerinnung. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak.222, 107 (1954) (a).Google Scholar
  227. Jürgens, R.: Funktion der Thrombocyten bei Blutung und Thrombose. Wien. klin. Wschr.1954 (b), 850.Google Scholar
  228. Jürgens, R., u.E. Deutsch (Herausgeber): Hämorrhagische Diathesen. Int. Symp. Wien 1955.Google Scholar
  229. Kabat, E. A.: Blood group substances. Their chemistry and immunochemistry. New York 1956.Google Scholar
  230. Kaznelson, P.: Thrombolytische Purpura. Z. klin. Med.87, 133 (1919).Google Scholar
  231. Kissmeyer-Nielsen, F.: Demonstration of platelet antibodies by heamagglutination of tannin coated erythrocytes. Vox Sang. (Basel)3, 123 (1953).Google Scholar
  232. Klein, E., P. Arnold, R. T. Earl andE. Wake: A practical method for the aseptic preparation of human platelet concentrates without loss of other blood elements. New Engl. J. Med.254, 1132 (1956).PubMedGoogle Scholar
  233. Klein, E., P. Arnold, R. T. Earl andE. Wake: Simple methods for the aseptic separation of blood components. Proc. 6. Congr. Int. Soc. Blood Transfusion, Boston 1956, p. 382. Basel u. New York 1958.Google Scholar
  234. Klein, E., D. Djerassi andS. Farber: Hemostasis following the administration of lyophilized platelet material in secondary thrombocytopenia. Proc. 6. Congr. Int. Soc. Hematol., Boston 1956, p. 525. New York 1958.Google Scholar
  235. —,S. Farber, G. Freeman andR. Fiorentino: The effects of varying concentrations of human platelets and their stored derivatives on the recalcification time of plasma. Blood11, 910 (1956).PubMedGoogle Scholar
  236. —, andR. Fiorentino: Effects of varying concentrations of platelets and their lyophilized derivatives on generation of thromboplastin. Proc. Soc. exp. Biol. (N. Y.)94, 357 (1957).Google Scholar
  237. —,R. Toch, S. Farber, G. Freeman andR. Fiorentino: Hemostasis in thrombocytopenic bleeding following infusion of stored frozen platelets. Blood11, 693 (1956).PubMedGoogle Scholar
  238. Köppel, G.: Elektronenoptische Untersuchungen zur Funktionsmorphologie der Thrombozyten und zum Gerinnungsablauf im normalen menschlichen Nativblut. Z. Zellforsch.47, 401 (1958).PubMedGoogle Scholar
  239. Koller, F.: Die Physiologie der Blutgerinnung. Ihre Bedeutung für die Klinik. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak.222, 89 (1954).Google Scholar
  240. —: Le facteur X. Rev. Hémat.10, 362 (1955).PubMedGoogle Scholar
  241. Koppel, J. L., andJ. H. Olwin: Dehydrogenase activities of human platelets. Fed. Proc.13, 244 (1954).Google Scholar
  242. Kotilainen, M. L., andA. Wilska: Observations on living thrombocytes under the anoptral contrast microscope. Ann. Med. exp. Fenn.33, 76 (1955).PubMedGoogle Scholar
  243. Kwaan, H. C., R. Lo andA. J. S. McFadzean: On the lysis of thrombi experimentally produced within veins. Brit. J. Haemat.4, 51 (1958).PubMedGoogle Scholar
  244. Laki, K.: The autocatalytic formation of thrombin and the clotting defect of hemophilic blood. Stud. Inst. Med. Chem. Univ. Szeged3, 5 (1943).Google Scholar
  245. —, andL. Lorand: On the stability of fibrin clots. Science108, 280 (1948).PubMedGoogle Scholar
  246. Larrieu, M. J., H. Caen, P. Grenet, J. Cayla etJ. Bernard: Hypoaccélérinémie congénitale (Parahémophilie). Sang27, 117 (1956).PubMedGoogle Scholar
  247. Lasch, H. G., I. Pfisterer u.K. Schimpf: Über das Verhalten des Gerinnungsfaktors VII im Kreislauf der Katze. Acta haemat. (Basel)17, 280 (1957).Google Scholar
  248. —, u.L. Roka: Zur Prothrombindildung in der Leber. Hoppe-Seylers Z. physiol. Chem.294, 30 (1953).Google Scholar
  249. Leathes, J. B., andJ. Mellanby: Thrombokinase from brain. J. Physiol. (Lond.)96, 38 P (1939).Google Scholar
  250. Lee, Ch.-Y., S. A. Johnson andW. H. Seegers: Clotting of blood with Russel’s viper venom. J. Mich. med. Soc.54, 801 (1955).PubMedGoogle Scholar
  251. —,S. A. Johnson andW. H. Seegers: Platelet cothromboplastin: A platelet factor related to the blood clotting mechanism. Thromb. Diath. haem.1, 16 (1957).Google Scholar
  252. Leeksma, C. H. W., andJ. A. Cohen: Determination of life-span of human blood platelets using labelled diisopropyl-fluorophosphate. Nature (Lond.)175, 552 (1955).Google Scholar
  253. Lenggenhager, K.: Die Lösung des hämophilen Blutungs- und Gerinnungsrätsels. Mitt. Grenzgeb. Med. Chir.44, 425 (1936).Google Scholar
  254. Lenggenhager, K.: Einige Klärungen in der Blutgerinnungsfrage. Schweiz. med. Wschr.1946, 410.Google Scholar
  255. Lenggenhager, K.: Weitere Fortschritte in der Blutgerinnungslehre. Leipzig 1949.Google Scholar
  256. Le Sourd, L., etP. Pagniez: Du rôle des hématoblastes dans la rétraction du caillot. C. R. Soc. Biol. (Paris)61, 109 (1906).Google Scholar
  257. ——: Nouvelles recherches sur le rôle des plaquettes dans la rétraction du caillot sanguin. C. R. Soc. Biol. (Paris)65, 400 (1908).Google Scholar
  258. ——: Recherches sur le rôle des plaquettes sanguines ou hématoblastes dans la coagulation du sang. J. Physiol. Path. gén.15, 812 (1913).Google Scholar
  259. Leupold, R.: Zur thromboplastischen Wirkung von Erythrozyten. Schweiz. med. Wschr.1955, 911.Google Scholar
  260. Lewis, J. A., andJ. H. Ferguson: Hypoproaccelerinemia. Blood10, 351 (1955).PubMedGoogle Scholar
  261. Loeb, L.: Über die Blutgerinnung bei Wirbellosen. Biochem. Z.24, 478 (1910).Google Scholar
  262. Loeber, J.: Zur Physiologie der Blutplättchen. Pflügers Arch. ges. Physiol.140 (1911).Google Scholar
  263. Loewy, A. G., andJ. T. Edsall: Studies on the formation of urea-insoluble fibrin. J. biol. Chem.211, 829 (1954).PubMedGoogle Scholar
  264. Lorand, L.: Interaction of thrombin and fibrinogen. Physiol. Rev.34, 742 (1954).PubMedGoogle Scholar
  265. Lozner, E. L., andF. H. L. Taylor: The effect of foreign surfaces on blood coagulation. J. clin. Invest.21, 241 (1942).PubMedGoogle Scholar
  266. Lüscher, E. F.: Untersuchungen über eine die Blutgerinnung fördernde Substanz aus dem Harne Hämophiler. Diss. Universität Bern 1946.Google Scholar
  267. —: Fibrinretraktion und Thrombozytenproteine. Helv. physiol. pharmacol. Acta11, C64 (1953).PubMedGoogle Scholar
  268. Lüscher, E. F.: Thrombozytenproteine und Gefäßpermeabilität, “Hämorrhagische Diathesen”, S. 117. Wien 1955.Google Scholar
  269. Lüscher, E. F.: Die physiologische Bedeutung der Thrombozyten. Schweiz. med. Wschr.1956(a), 345.Google Scholar
  270. —: Vicous metamorphosis and clot retraction. Vox Sang. (Basel)1, 133 (1956(b)).Google Scholar
  271. Lüscher, E. F.: Glukose als Cofaktor bei der Retraktion des Blutgerinnsels. Experientia (Basel)12, 294 (1956) (c).Google Scholar
  272. Lüscher, E. F.: Actes 2. Symp. Fondation V. Baldacci, Lissabon 1957 (a) (im Druck).Google Scholar
  273. Lüscher, E. F.: Ein fibrinstabilisierender Faktor aus Thrombocyten. Schweiz. med. Wschr.1957(b), 1220.Google Scholar
  274. Lüscher, E. F.: Unveröffentlichte Ergebnisse 1958.Google Scholar
  275. Lyttleton, J. W.: Biophysical studies on thrombin and antithrombin and the kinetics of their reaction. Thesis, Univ. of London 1950.Google Scholar
  276. Macfarlane, R. G.: The normal haemostatic mechanism and its failure in the haemorrhagic states. Thesis, University of London 1938.Google Scholar
  277. —: Vitamin K and the estimation of prothombin. Proc. roy. Soc. Med.35, 410 (1942).Google Scholar
  278. —: Blood coagulation. Physiol. Rev.36, 479 (1956).PubMedGoogle Scholar
  279. Magalini, S. I., andM. Stefanini: Clot- retraction promoting factor (retractin) in platelets and tissues. Science123, 796 (1956) (a).PubMedGoogle Scholar
  280. ——: Failure of serotonin in inducing retraction of a platelet poor plasma clot. Proc. Soc. exp. Biol. (N. Y.)90, 615 (1956) (b).Google Scholar
  281. ——: Studies on platelets XVI: Glutamic oxaloacetic transaminase—activity on human platelets. Proc. Soc. exp. Biol. (N. Y.)91, 404 (1956) (c).Google Scholar
  282. Magalini, S. I., andM. Stefanini: A platelet factor responsible for clot retraction. Lancet1956 I (d), 246.Google Scholar
  283. Mann, F. D.: A preliminary reaction of coagulation factors found in plasma and serum. Circulat. Res.5, 481 (1957).PubMedGoogle Scholar
  284. —,M. Hurn andN. Barker: Platelets and the coagulation defect caused by dicumarol Amer. J. clin. Path.21, 814 (1951).Google Scholar
  285. —— andT. B. Magath: Observations on the conversion of prothrombin to thrombin. Proc. Soc. exp. Biol. (N. Y.)66, 33 (1947).Google Scholar
  286. Marbet, R., u.A. Winterstein: Synonyma der Gerinnungsfaktoren. 1. Int. Tagg über Thrombose und Embolie, S. 53, Basel 1955 (a).Google Scholar
  287. ——: Der Heparintoleranztest. Ärztl. Forsch.10, 460 (1955) (b).Google Scholar
  288. Margolis, J.: Plasma pain-producing substances and blood clotting. Nature (Lond.)180, 1464 (1957).Google Scholar
  289. Marx, R.: Verh.ber. 58. Tagg Dtsch. Ges. Inn. Med. Dtsch. med. Wschr.1952, 925.Google Scholar
  290. —: Verh. 3. Symp. Dtsch. Arbeitsgemeinschaft für Blutgerinnungsforsch., Thromb. Diath. haem.2, 192 (1958).Google Scholar
  291. —, u.S. Derlath: Über eine Methode zur vergleichend quantitativen Bestimmung der Thrombozytenadhäsivität an blutfremden Oberflächen unter gleichzeitiger Erfassung der relativen Blutviskosität. Blut3, 247 (1957).PubMedGoogle Scholar
  292. Maspes, V., T. Verrastro, E. Coelho e.M. Jamra: Agglutinas plaqueteras I. Agglutination inespecifica por un factor de la coagulation contenido en el suero normale (F. VII). Sangre1, 156 (1956).Google Scholar
  293. Matthes, M., u.K. Sickinger: Herstellung von Thrombozytenkonzentraten für Transfusionszwecke bei Verwendung verschiedener Dextranfraktionen. Acta haemat. (Basel)15, 278 (1956).Google Scholar
  294. Maupin, B.: Les plaquettes sanguines de l’homme. Paris 1954.Google Scholar
  295. —, etR. Chary: Présentation d’une nouvelle méthode de séparation des leucocytes et des plaquettes sanguines. Sang23, 336 (1952).PubMedGoogle Scholar
  296. McClaughry, R. I., andW. H. Seegers: Prothrombin, thromboplastin, ac.-globulin and platelet accelerator. Quantitative interrelationships. Blood5, 503 (1950).Google Scholar
  297. Mertz, E. T., W. H. Seegers andH. P. Smith: Inactivation of prothrombin by purified thrombin solution. Proc. Soc. exp. Biol. (N. Y.)41, 657 (1939).Google Scholar
  298. Miller, K. D.: Structural studies of the prothrombin-thrombin system. Vox Sang. (Basel)3, 63 (1958).Google Scholar
  299. —, andH. van Vunakis: The effect of diisopropylfluoro-phosphate on the proteinase and esterase activities of thrombin and on prothrombin and its activators. J. biol. Chem.223, 227 (1956).PubMedGoogle Scholar
  300. Milstone, J. H.: The chain reaction of the blood clotting mechanism in relation to the theory of hemostasis and thrombosis. Blood4, 1920 (1949).Google Scholar
  301. —: Effect of blood thrombokinase as influenced by soybean trypsin inhibitor, ultracentrifugation and accessory factors. J. gen. Physiol.38, 757 (1955).PubMedGoogle Scholar
  302. Minor, A. H., andL. Burnett: A method for separating and concentrating platelets from normal human blood. Blood7, 693 (1952).PubMedGoogle Scholar
  303. Mocchi, N.: La morfologia delle piastrine nell’uomo normale e dopo trattamento con ormone maschile. Haematologica36, 605 (1952).PubMedGoogle Scholar
  304. Monkhouse, F. C., andD. W. Clarke: Purification of antithrombin and heparin cofactor. Canad. J. Biochem.35, 373 (1957).PubMedGoogle Scholar
  305. —,E. C. France andW. H. Seegers: Studies on the antithrombin and heparin cofactor activities of a fraction absorbed from plasma by aluminum hydroxyde. Circulat. Res.3, 397 (1955).PubMedGoogle Scholar
  306. Moolten, S. E., andL. Vroman: The adhesiveness of blood platelets in thromboembolism and hemorrhagic disorders. I. Measurement of platelet adhesiveness by the glass wool filter. Amer. J. clin. Path.19, 701 (1949).Google Scholar
  307. Morawitz, P.: Die Chemie der Blutgerinnung. Ergebn. Physiol.4, 307 (1905).Google Scholar
  308. Morgan, W. T. J.: The human AB 0 blood group substances. Experientia (Basel)3, 257 (1947).Google Scholar
  309. Morita, H.: Studies on amino acids in platelets. Acta haemat. jap.16, 76 (1953).Google Scholar
  310. Morita, H.: Studies on blood platelets. Proc. 6. Congr. Int. Soc. Hematol., Boston 1956, p. 561. New York 1958.Google Scholar
  311. Morrison, P., andW. H. Rothman: Agglutination of blood cells in limulus polyphemus. Proc. Soc. exp. Biol. (N. Y.)94, 21 (1957).Google Scholar
  312. Mortensen, O.: Thrombocythaemia haemorrhagica. Acta med. scand.129, 547 (1948).PubMedGoogle Scholar
  313. Moulinier, J., andF. Mesnier: Use of lipoid platelet extracts in the agglutination reaction of sensitized particles. Vox Sang. (Amsterdam)4, 199 (1954).Google Scholar
  314. Moureau, P., etA. André: Mise en évidence des antigènes de type A et B dans les plaquettes. C. R. Soc. Biol. (Paris)148, 174 (1954) (a).Google Scholar
  315. ——: Blood groups of human blood platelets. Nature (Lond.)174, 88 (1954) (b).Google Scholar
  316. Murray, M., Sh. A. Johnson andW. H. Seegers: Activation of purified prothrombin in association with synthetic organic compounds and platelet extract. Science119, 293 (1952).Google Scholar
  317. ———: Relationship of certain antihistamine drugs to the activation of purified prothrombin. Amer. J. Physiol.178, 10 (1954).PubMedGoogle Scholar
  318. Nikolaeva, N. I.: Thrombocytes as one of the sources of blood enzymes. Byull. Eksp. Biol. Med.22, 24 (1946).Google Scholar
  319. Nour-Eldin, F., andJ. F. Wilkinson: Two stages in the formation of active plasma thromboplastin. Nature (Lond.)178, 856 (1956) (a).Google Scholar
  320. ——: The separation of human and bovine plasma thromboplastin with ether and a study of its properties. J. Physiol. (Lond.)132, 164 (1956) (b).Google Scholar
  321. O’Brien, J. R.: The similarity of action of phosphatidyl ethanol-amine and platelets in blood coagulation. J. clin. Path.9, 47 (1956).PubMedGoogle Scholar
  322. —: The effect of some fatty acids and phospholipids on blood coagulation. Brit. J. exp. Path.38, 529 (1957).PubMedGoogle Scholar
  323. Odell, T. T., andB. Anderson: Isolation of a sulfated mucopolysaccharide from blood platelets of rats. Proc. Soc. exp. Biol. (N. Y.)94, 151 (1957).Google Scholar
  324. —, andA. C. Upton: Distribution of calcium in platelets and bone marrow of rats. Acta haemat. (Basel)14, 291 (1955).Google Scholar
  325. Oeri, J., M. Matter, H. Isenschmid, C. Hauser u.F. Koller: Angeborener Mangel an Faktor V (Parahämophilie) verbunden mit echter Hämophilie A bei zwei Brüdern. Mod. Probl. Pädiatr.1, 575 (1954).Google Scholar
  326. Olef, J.: Determination of platelet volume. J. Lab. clin. Med.23, 166 (1937).Google Scholar
  327. Øllgaard, E.: Clot retraction as a quantitative test of the function and agglutinability of the blood platelets. Acta haemat. (Basel)6, 220 (1951).Google Scholar
  328. Onaka, M.: Über Oxydationen im Blut. Hoppe-Seylers Z. physiol. Chem.71 193 (1911).Google Scholar
  329. Opitz, H., u.W. Schober: Klinische und experimentelle Studien über die Bedeutung der Blutplättchen für die Retraktilität des Blutkuchens. Jb. Kinderheilk53, 189 (1923).Google Scholar
  330. Owren, P. A.: The coagulation of blood; Investigations on an new clotting factor. Acta med. scand. Suppl.194 (1947).Google Scholar
  331. —: The fifth coagulation factor — preparation and properties. Biochem. J.43, 136 (1948).Google Scholar
  332. Owren, P. A.: The present state of the converting and accelerator factors in prothrombin conversion. Thrombose und Embolie. 1. Int. Tagg, Basel. 1954, S. 65. Basel 1955.Google Scholar
  333. —,S. I. Rapaport, P. Hjort andK. Aas: The biochemistry of thromboplastin, its formation and action. Sang25, 752 (1954).PubMedGoogle Scholar
  334. Oye, E. L. van: Note sur les acides nucléiques des plaquettes sanguines. Haematologica31, 689 (1948).Google Scholar
  335. Page, I. H.: Serotonin (5-hydroxytryptamine). Physiol. Rev.34, 563 (1954).PubMedGoogle Scholar
  336. —: Serotonin (5-hydroxytryptamine); the last four years. Physiol. Rev.38, 277 (1958).PubMedGoogle Scholar
  337. Parrot, J. L. etM. Gabe: Sur la répartition de l’histamine dans les éléments constitutifs du sang humain. C. R. Soc. Biol. (Paris)139, 965 (1945).Google Scholar
  338. Pedrazzini, A., u.E. Salvidio: Die Fermente der menschlichen Thrombozyten und ihre wahrscheinliche Bedeutung im Mechanismus der Blutstillung (Hämostase). Schweiz. med. Wschr.1956, 1097Google Scholar
  339. Penner, J. A., F. Duckert, Sh. A. Johnson andW. H. Seegers: Conversion of prothrombin to autoprothrombin II. Canad. J. Biochem.34 1199 (1956).PubMedGoogle Scholar
  340. Perry, S., andCh. G. Craddock jr.: Platelet adsorptive properties and platelet extracts in thromboplastin generation. Blood13, 177 (1958).PubMedGoogle Scholar
  341. Peterson, E. A., andH. A. Sober: Chromatography of proteins. I. Cellulose ion-exchange adsorbents. J. Amer. chem. Soc.78, 751 (1956).Google Scholar
  342. Pettavel, J., etB. Vuilleret: Les variations de la coagulabilité appréciéesin vitro par le test à l’héparine de Marbet et Winterstein en fonction des valeurs de Quick et de differentes concentrations plaquettaires. Helv. chir. Acta24, 39 (1957).PubMedGoogle Scholar
  343. Pinniger, J. L., andF. I. G. Prunty: Some observations on the blood clotting mechanism: The role of fibrinogen and platelets with reference to a case of congenital afibrinogenaemia. Brit. J. exp. Path.27, 200 (1946).PubMedGoogle Scholar
  344. Quick, A. J.: On the action of heparin and its relation to thromboplastin. Amer. J. Physiol.115, 317 (1936).Google Scholar
  345. —: The normal antithrombin of the blood and its relation to heparin. Amer. J. Physiol.123, 712 (1938).Google Scholar
  346. —: Studies on the enigma of the hemostatic dysfunction of hemophilia. Amer. J. med. Sci.214, 272 (1947).PubMedGoogle Scholar
  347. Quick, A. J.: The physiology and pathology of haemostasis. London u Philadelphia 1951.Google Scholar
  348. Quick, A. J.: Hemorrhagic diseases. Philadelphia 1957.Google Scholar
  349. —, andE. Epstein: Thromboplastic activity in human blood. J. appl. Physiol.4, 840 (1952).PubMedGoogle Scholar
  350. —,J. G. Georgatsos andC. V. Hussey: The clotting activity of human erythrocytes. Theoretical and clinical implications. Amer. J. med. Sci.228, 207 (1954).PubMedGoogle Scholar
  351. —, andC. V. Hussey: Initiation of the clotting of blood. Proc. Soc. exp. Biol. (N. Y.)80, 40 (1952).Google Scholar
  352. Ranvier, M.: Du mode de formation de la fibrine dans le sang extrait des vaisseaux. C. R. Soc. Biol. (Paris)5, 46 (1873).Google Scholar
  353. Rapaport, S. I., K. Aas andP. A. Owren: The effect of glass upon the activity of the various plasma clotting factors. J. clin. Invest.34, 9 (1955).PubMedGoogle Scholar
  354. Ratnoff, O. D.: A familial trait characterized by deficiency of a clot promoting fraction of plasma. J. Lab. clin. Med.44, 915 (1954).Google Scholar
  355. Ratnoff, O. D., andA. Margolius jr.: The hereditary nature of Hageman trait. Proc. 6. Congr. Int. Soc. Hematol., Boston 1956, p. 513. New York 1958.Google Scholar
  356. —, andJ. M. Rosenblum: Role of Hageman-factor in the initiation of clotting by glass. J. Lab. clin. Med.50, 941 (1957).Google Scholar
  357. Reid, G.: A pharmacologically active substance in serum and platelets which stimulates suprarenal medulla. J. exp. Biol. Med.26, 107 (1948).Google Scholar
  358. Remde, W.: Der Einfluß von Heparin auf die Bildung der Blutthrombokinase. Z. ges. inn. Med.11, 81 (1956).PubMedGoogle Scholar
  359. Rheingold, J. J., andG. B. Wislocki: Histochemical methods applied to hematology. Blood3, 641 (1948).PubMedGoogle Scholar
  360. Ricci, M.: Modificazioni del sangue trattato con resina a scambio ionico (Amberlite I. R. 120). Sangue25, 213 (1952).PubMedGoogle Scholar
  361. Richter, (1921) Zit. nachMaupin (1954).Google Scholar
  362. Robb-Smith, A. H. T.: The Rubicon: Changing views on thrombosis and blood coagulation. Brit. med. Bull11, 70 (1955).PubMedGoogle Scholar
  363. Robertis, E. de: Electron microscope observations of the platelet-fibrin relationship in blood clotting. Blood10, 528 (1955).Google Scholar
  364. —,P. Paseyro andM. Reissig: Electron microscopic studies of the action of thrombin on blood platelets. Blood8, 587 (1953).Google Scholar
  365. Rohr, K., u.F. Koller: Über die Abstammung der Thrombozyten. Klin. Wschr.1936, 1549.Google Scholar
  366. Ross, J.: Blood coagulation as a continuous process. Thromb. Diath. haem.1, 471 (1957).Google Scholar
  367. Rosenthal, R. L., O. H. Dreskin andN. Rosenthal: New hemophilialike disease caused by deficiency of a third plasma thromboplastin factor. Proc. Soc. exp. Biol. (N. Y.)82, 171 (1953).Google Scholar
  368. Roskam, J.: Contribution à l’étude de la physiologie normale et pathologique dù globulin (plaquettes de Bizzozero). Arch. int. Physiol.20, 240 (1923).Google Scholar
  369. —: La synérèse des caillots fibrineux ne résulte pas d’une “fonction rétractante” des globulins (plaquettes de Bizzozero). C. R. Soc. Biol. (Paris)95, 1122 (1926).Google Scholar
  370. Rothman, S., E. Adelson, A. Schwebel andR. D. Langdell: Adsorption of C14 dextran to human blood platelets and red blood cellsin vitro. Vox Sang. (Basel)1958 (to be published).Google Scholar
  371. Rovatti, B.: Modificazioni di retrattilità del coagulo da trattamento con ultrasuoni. Sangue1950, 3.Google Scholar
  372. —: Indice d’adhésivité et agglutinogramme des plaquettes: nouvelles épreuves pour l’étude des affections hémorrhagipares et thrombogènes. Sang22, 451 (1951).PubMedGoogle Scholar
  373. Ruggieri, P., eG. Bolognesi: Gruppi A e B delle piastrine. Boll. Soc. Ital. Ematol.2, 127 (1954).Google Scholar
  374. Salmon, J.: Études immunoélectrophorétiques des antigènes plaquettaires humains. Schweiz. med. Wschr.1958, 1047.Google Scholar
  375. —, etY. Bounameaux: Recherches sur l’antigènicité des plaquettes et du fibrinogène bovins. C. R. Soc. Biol. (Paris)150, 2278 (1956).Google Scholar
  376. ——: Situation du fibrinogène décelé dans les thrombocytes bovins isolés et lavés. Arch. int. Physiol.65, 502 (1957).PubMedGoogle Scholar
  377. —,M. Verstraete etY. Bounameaux: Fibrinogène plaquettaire et afibrinogénémie. Arch. int. Physiol.65, 632 (1957).PubMedGoogle Scholar
  378. Saltzman, G. F.: The origin of blood platelets. Acta med., scand. Suppl.1949, 221.Google Scholar
  379. Salvidio, E.: Biochemical aspects of blood platelets. (Peptidase, acid and alkaline phosphatase activity in normal subjects, during menstruation and in some hemorrhagic disorders). Acta haemat. (Basel)11, 301 (1954).Google Scholar
  380. Salvidio, E., I. Pannaciulli andE. Bianchini: The action of coumarin anticoagulants and of vitamin K, on some enzymes of human blood platelets. 5 Kongr. Europ. Ges. Hämatol. 1956, S. 499.Google Scholar
  381. Samuels, P. B., andD. R. Webster: The role of venous endothelium in the inception of thrombosis. Ann. Surg.136, 422 (1952).PubMedGoogle Scholar
  382. Sarkar, N. K., G. Chaterjee andR. Banerjee: Lipids in blood clotting. Wayne University 6. Ann. Symp. on blood. Vox Sang. (Basel)1, 567 (1957).Google Scholar
  383. Savitsky, J. P.: A plasma factor responsible for platelet adhesiveness and clot retraction acceleration. Blood8, 1091 (1953).PubMedGoogle Scholar
  384. Schayer, R. W., andY. Kobayashi: Histidin carboxylase and histamin—binding in rabbit platelets. Proc. Soc. exp. Biol. (N. Y.)92, 653 (1956).Google Scholar
  385. Schmidt, A.: Zur Blutlehre. Leipzig 1892.Google Scholar
  386. Schneider, C. L., E. B. Claxton, C. H. Hughes andS. A. Johnson: Bovine platelets in large quantities. Properties and activities concerned with hemostasis. Amer. J. Physiol.179, 236 (1954).PubMedGoogle Scholar
  387. Schultze, M.: Ein heizbarer Objekttisch und seine Verwendung bei Untersuchungen des Blutes. Arch. mikr. Anat.1, 1 (1865).Google Scholar
  388. Seegers, W. H.: Activation of purified prothrombin. Proc. Soc. exp. Biol. (N. Y.)72, 677 (1949).Google Scholar
  389. —: Blood coagulation. Enzymes2, 1106 (1951).Google Scholar
  390. —: Coagulation of blood. Harvey Lect.47, 180 (1951/52).Google Scholar
  391. —: The purification of prothrombin. Rec. Progr. Chem.13, 143 (1953).Google Scholar
  392. —: Vue actuelle sur le rôle des plaquettes dans la coagulation sanguine. Sang27, 866 (1956).PubMedGoogle Scholar
  393. —, andN. Alkjaersig: The preparation of prothrombin derivates and an indication of their properties. Arch. Biochem.61, 1 (1956).PubMedGoogle Scholar
  394. ——, andS. A. Johnson: Formation of autoprothrombin in solution containing purified prothrombin and purified platelet factor 3. Amer. J. Physiol.181, 589 (1955).PubMedGoogle Scholar
  395. —, andS. A. Johnson: Conversion of prothrombin to autoprothrombin II (platelet cofactor II) and its relation to the blood clotting mechanism. Amer. J. Physiol.184, 259 (1956).PubMedGoogle Scholar
  396. ——,C. Fell andN. Alkjaersig: Activation of purified prothrombin with platelets combined with various crude biochemical preparations. Amer. J. Physiol.178, 1 (1954).PubMedGoogle Scholar
  397. ——, andJ. A. Penner: Quantitative concepts related to prothrombin and autoprothrombin I activity. Canad. J. Biochem.34, 887 (1956).PubMedGoogle Scholar
  398. —, andR. H. Landaburu: Inhibition of prothrombin activation in sodium citrate solutions. Proc. Soc. exp. Biol. (N. Y.)95, 710 (1957).Google Scholar
  399. —,E. C. Loomis andJ. M. Vandenbelt: Preparation of prothrombin products: Isolation of prothrombin and its properties. Arch. Biochem.6, 85 (1945).Google Scholar
  400. Seligmann, M., B. Goudemand, A. Janin, J. Bernard etP. Grabar: Etudes immunochimiques sur la présence de fibrinogène dans les extraits de plaquettes humaines lavées et dans certains extraits leucocytaires. Rev. Hémat.12, 302 (1957).PubMedGoogle Scholar
  401. Setna, S. S., andR. L. Rosenthal: Intermediate stages in platelet alterations during coagulation. Acta haemat.19, 209 (1958).Google Scholar
  402. Sharp, A. A.: Viscous metamorphosis of blood platelets: A study of the relationship to coagulation factors and fibrin formation. Brit. J. Haemat.4, 28 (1958).PubMedGoogle Scholar
  403. Sherry, S., andN. Alkjaersig: Studies on the fibrinolytic enzyme of human plasma. Thromb. Diath. haem.1, 264 (1957).Google Scholar
  404. Shinowara, G. Y.: Enzyme studies on human blood. XI. The isolation and characterization of thromboplastic cell and plasma components. J. Lab. clin. Med.38, 11 (1951).PubMedGoogle Scholar
  405. —: Thromboplastic cell component, the lipoprotein of erythrocytes and platelets. J. biol. Chem.225, 63 (1957).PubMedGoogle Scholar
  406. Shore, P. A., A. Pletscher, E. G. Tomich, R. Kuntzman andB. B. Brodie: Release of blood platelet serotonin by reserpine and lack of effect on bleeding time. J. Pharmacol.117, 232 (1956).Google Scholar
  407. Shulman, N. R.: Studies on the inhibition of proteolytic enzymes by serum. II. Demonstration that separate proteolytic inhibitors exist in serum; their distinct properties and the specificity of their action. J. exp. Med.95, 593 (1952).PubMedGoogle Scholar
  408. Smith, C., M. Robinson andR. Tyson: Reaction oxydase as applied to megakaryocytes and platelets of the rat. Anat. Rec.70, 139 (1938).Google Scholar
  409. —,E. D. Warner andK. M. Brinkhous: Prothrombin deficiency and the bleeding tendency in liver injury (chloroform intoxication). J. exp. Med.66, 801 (1937).PubMedGoogle Scholar
  410. Sober, H. A., F. J. Gutter, M. M. Wyckoff andE. A. Peterson: Chromatography of proteins: II. Fractionation of serum protein on anion exchange cellulose. J. Amer. chem. Soc.78, 756 (1956).Google Scholar
  411. Soulier, J. B.: La consommation de la prothrombine pendant la coagulation du sang veineux et du sang capillaire. Nouvelle méthode d’investigation des syndromes hémorrhagiques. Rev. Hémat.3, 302 (1948).Google Scholar
  412. —: Activité thromboplastique du sang et du plasma conservé. Vox Sang. (Basel), N. S.,1, 110 (1956).Google Scholar
  413. —, etA. G. Le Bolloch: Le test de tolérance à l’héparine „in vitro”. Rev. Hémat.5, 148 (1950).PubMedGoogle Scholar
  414. ——: The „in vitro” heparin tolerance test in the control of dicumarol therapy. Acta med. scand.140, 132 (1951).PubMedGoogle Scholar
  415. —, etM. J. Larrieu: Nouvelle méthode de diagnostic de l’hémophilie. Dosage des facteurs antihémophiliques A et B. Sang24, 205 (1953).PubMedGoogle Scholar
  416. O. Wartelle etD. Ménaché: Caractères différentiels des facteurs Hageman et PTA. Rôle du contact dans la phase initiale de la coagulation. Rev. franç. Ét. clin. biol.3, 263 (1938).Google Scholar
  417. Spaet, T. H.: Anticoagulants derived from blood platelets. J. appl. Physiol.11, 119 (1957).PubMedGoogle Scholar
  418. S. Bauer andS. Melamed: Hemorrhagic thrombocythemia. A blood coagulation disorder. Arch. intern. Med.98, 377 (1956).Google Scholar
  419. —, andE. S. Garner: Studies on the storage lability of human antihemophilic factor. J. Lab. clin. Med.46 (III) (1955).Google Scholar
  420. Stefanini, M.: Autocatalytic formation of thrombin in blood coagulation. Acta med. scand.140, 290 (1951).PubMedGoogle Scholar
  421. —: Mechanism of blood coagulation in normal and pathological conditions. Amer. J. Med.14, 64 (1953).PubMedGoogle Scholar
  422. —, andE. W. Campbell: Studies on platelets: XII. Isolation and purification of the platelet thromboplastic factor; its physicochemical and biological propertiesin vitro andin vivo. Rev. Hémat.9, 576 (1954).PubMedGoogle Scholar
  423. —, andW. Dameshek: Collection, preservation and transfusion of platelets. New Engl. J. Med.248, 797 (1953).PubMedGoogle Scholar
  424. Stefanini, M., andW. Dameshek: The hemorrhagic disorders. New York u. London 1955.Google Scholar
  425. Stefanini, M., andS. Kistner: Transfusion of platelets, platelet derivatives and platelet substitutes in the management of thrombocytopenie states. Proc. 6. Congr. Int. Soc. Blood Transfusion, Boston 1956, p. 378. Basel u. New York 1958.Google Scholar
  426. N. Krinsky andS. I. Magalini: Studies on platelets. XIX: Carotenoid pigments in human platelets. J. Lab. clin. Med.50, 225 (1957).PubMedGoogle Scholar
  427. —, andI. S. Murphy: Studies on platelets. XIV. Human platelets as source of antifibrinolysin. J. clin. Invest.35, 355 (1956).PubMedGoogle Scholar
  428. —, andJ. H. Silverberg: Studies on platelets: I. The relation of platelet agglutination to the coagulation mechanism. Amer. J. clin. Path.21, 1030 (1951).Google Scholar
  429. Stormorken, H.: The effect of trypsin on blood coagulation and the mechanism of its action. J. Lab. clin. Med.48, 519 (1956).PubMedGoogle Scholar
  430. Storti, E., S. Perugini andM. Soldati: Cytochemical investigations of normal megakaryocytes and platelets. Acta haemat. (Basel)10, 144 (1953).Google Scholar
  431. Studer, A., u.A. Winterstein: Probleme der Blutgerinnung. I. Bestimmung des Heparins auf gerinnungsphysiologischem Wege. Helv. physiol. pharmacol. Acta9, 6 (1951).PubMedGoogle Scholar
  432. Szirmai, E., u.E. Bajusz: Der Zusammenhang der Thrombozyten-Succinodehydrase-Aktivität mit der Blutgerinnung. Verh. 5. Kongr. Europ. Ges. für Hämat., Freiburg 1955, S. 655. Berlin-Göttingen-Heidelberg 1955.Google Scholar
  433. Telfer, T. P., K. W. Denson andD. R. Wright: A „new” coagulation defect. Brit. J. Haemat.2, 308 (1956).PubMedGoogle Scholar
  434. Tinacci, F., eC. Cessi: Alcune osservazioni sulla conglutinazione piastrinica dopo azione della jaluronidasa sulla struttura chimica delle piastrine. Boll. Soc. ital. Biol. sper.28, 283 (1952).PubMedGoogle Scholar
  435. Tocantins, L.: The mammalian blood platelet in health and disease. Medicine (Baltimore)17, 155–258 (1938).Google Scholar
  436. Trevan, J. W., andR. G. Macfarlane: Rep. med. Res. Coun. (Lond.)1936/37, 143 (1938).Google Scholar
  437. Tropeano, L., eE. Cacciola: Sulla attività tromboplastica delle cellule leuchemiche. Boll. Soc. ital. Ematol.3, 2 (1955).Google Scholar
  438. Tullis, J. L.: Separation and purification of leucocytes and platelets. Blood7, 891 (1952).PubMedGoogle Scholar
  439. Tullis, J. L.: Blood cells and plasma proteins. New York 1953.Google Scholar
  440. —: Newer technics for the separation and fractionation of whole blood. N. Y. St. J. Med.53, 525 (1953).—Tullis, J. L., Trends in platelet research. N. Y. St. J. Med.53, 542 (1953).Google Scholar
  441. Tullis, J. L.: Preservation of platelets 8. Conf. on plasma and cellular elements of the blood, Boston 1954.Google Scholar
  442. Tullis, J. L., andP. Baudanza: Preservation of platelet concentrates for treatement of thrombocytopenic bleeding. 10. Conf. on plasma proteins and cellular elements of the blood. Boston 1956.Google Scholar
  443. Turpini, R.: Further data on the evaluation of platelet ac-globulin and its plasmatic origin. Experientia (Basel)12, 220 (1956).Google Scholar
  444. Valette, G., B. Maupin etH. Huidobro: Plaquettes sanguines et histaminase. C. R. Soc. Biol. (Paris)145, 313 (1951).Google Scholar
  445. Voit, K.: Zur Frage der Kernsubstanz in den Thrombozyten. Ärztl. Forsch.2, 13 (1948).Google Scholar
  446. —, u.H. Kempa: Über den Nachweis von echter Kernsubstanz in den Thrombozyten. Z. Biol.95, 635 (1934).Google Scholar
  447. Vries, S. I. de, H. K. Kettenborg andE. T. van der Pol: Verbandtussen een factor uit rode bloedcellen en de forming van thromboplastine. Ned. T. Geneesk.99, 2967 (1955).Google Scholar
  448. Vulpian, A.: Des corpuscules incoleurés et des leucocytes du sang. C. R. Soc. Biol. (Paris)25, 49 (1873).Google Scholar
  449. Wachstein, M.: The distribution of histochemically demonstrable glycogen in human blood and bone marrow cells. Blood4, 54 (1949).PubMedGoogle Scholar
  450. Wagner, R.: The estimation of glycogen in whole blood and white cells. Arch. Biochem.11, 249 (1946).PubMedGoogle Scholar
  451. N. Meyerriecks andC. Z. Berman:In vitro effects of x-Radiation on white blood cells and blood platelets. Blood12, 733 (1957).PubMedGoogle Scholar
  452. —— andR. Sparaco: Enzyme studies on white blood cells and blood platelets. V. Dehydrogenase activity. Arch. Biochem.61, 278 (1956).PubMedGoogle Scholar
  453. Wallach, D. F. H., D. M. Surgenor andB. B. Steele: Calcium-lipid complexes in human platelets. Blood13, 589 (1958).PubMedGoogle Scholar
  454. Walther, G.: Über die Gerinnungsaktivität hämolysierter menschlicher Erythrocyten. Blut2, 211 (1956).PubMedGoogle Scholar
  455. Warburg, O.: Untersuchungen über die Oxydationsprozesse in Zellen. Münch. med. Wschr.1911, 289.Google Scholar
  456. Ware, A. G., J. L. Fahey andW. H. Seegers: Platelet extracts, fibrin formation and interaction of purified prothrombin and thromboplastin. Amer. J. Physiol.154, 140 (1948).PubMedGoogle Scholar
  457. —, andW. H. Seegers: Serum ac-globulin; Formation from plasma ac-globulin: Role in blood coagulation; partial purification, properties and quantitative determination. Amer. J. Physiol.152, 567 (1948).PubMedGoogle Scholar
  458. Waugh, T. R., andD. W. Ruddick: A test for increased coagulability of the blood. Canad. med. Ass. J.50, 547 (1944).PubMedGoogle Scholar
  459. Wenckert, A., andJ. M. Nilsson: Thromboplastin and Russel’s viper venom—Investigation on the activation of prothrombin. Scand. J. clin. Lab. Invest.7, Suppl. 15 (1955).Google Scholar
  460. Wilbrandt, W., E. F. Lüscher u.H. Asper: Der Einfluß von Thrombozytenproteinen auf die Permeabilität der Blutkapillaren. Helv. physiol. pharmacol. Acta14, C 81 (1956).Google Scholar
  461. Willi, H.: Über den Bau und die Funktion der Megakaryocyten und ihre, Beziehungen zur thrombopenischen Purpura. Folia haemat. (Lpz.)53, 426 (1935).Google Scholar
  462. Wolf, P.: Lipid extracts of platelets and brain as substitutes for platelets in coagulation tests. Brit. J. Haemat.2, 375 (1956).PubMedGoogle Scholar
  463. Wolpers, C., u.H. Ruska: Strukturuntersuchungen zur Blutgerinnung. Klin. Wschr.1939, 1077.Google Scholar
  464. Wright, H. P.: The adhesiveness of blood platelets in normal subjects with varying concentrations of anticoagulants. J. Path. Bact.53, 255 (1941).Google Scholar
  465. —: Changes in the adhesiveness of blood platelets following parturition and surgical operations. J. Path. Bact.54, 461 (1942).Google Scholar
  466. — andG. R. Minot: The viscous metamorphosis of the blood platelets. J. exper. Med.26, 395 (1917).Google Scholar
  467. Zajicek, J.: Studies on the histogenesis of blood platelets. II. Quantitative determination of acetylcholinesterase activity in single megakaryocytes from various mammals. Acta haemat. (Basel)15, 296 (1956).Google Scholar
  468. —, andN. Datta: Investigation on the acetylcholinesterase activity of erythrocytes, platelets and plasma in different animal species. Acta haemat. (Basel)9, 115 (1953).Google Scholar
  469. Zatti, P.: Sulle cause dell’agglutinazione delle piastrine nel sangue in via di coagulazione. Boll. Soc. ital. Biol. sper.24, 22 (1948).Google Scholar
  470. Zimmermann, U.: Über die Formgebilde des menschlichen Blutes in ihrem näheren Verhältnis zum Prozesse der Entzündungen und Eiterung. Rusts Mag. ges. Heilk.66, 171 (1846).Google Scholar
  471. Zingoni, U.: Sulla presenza di glicogena nei megacariociti e nelle piastrine del sangue. Arch. fisiol.51, 216 (1951).Google Scholar
  472. Zucker, M. B.: Platelet agglutination and vasocontriction as factors in spontaneous hemostasis in normal, thrombocytopenic, heparinized and hypoprothrombinemic blood. Amer. J. Physiol.148, 275 (1947).PubMedGoogle Scholar
  473. —, andJ. Borrelli: Reversible changes in platelet morphology produced by anticoagulants and by cold. Blood9, 602 (1954).PubMedGoogle Scholar
  474. ——: Quantity, assay and release of serotonin in human platelets. J. appl. Physiol.7, 425 (1955) (a).PubMedGoogle Scholar
  475. ——: Relationship of some blood clotting factors to serotonin release from washed platelets. J. appl. Physiol.7, 432 (1955) (b).PubMedGoogle Scholar
  476. ——: Viscous metamorphosis of blood platelets produced by thrombin. Fed. Proc.14, 168 (1955) (c).Google Scholar
  477. —,B. K. Friedman andM. M. Rapport: Identification and quantitative determination of serotonin in blood platelets. Proc. Soc. exp. Biol. (N. Y.)85, 282 (1954).Google Scholar

Copyright information

© Springer-Verlag 1959

Authors and Affiliations

  • E. F. Lüscher
    • 1
  1. 1.Theodor-Kocher-InstitutBern(Schweiz)

Personalised recommendations